Su Ming, Bansal Anil K, Mantovani Roberto, Sodek Jaro
Canadian Institutes of Health Research Group in Matrix Dynamics, Faculty of Dentistry, University of Toronto, ON.
J Biol Chem. 2005 Nov 18;280(46):38365-75. doi: 10.1074/jbc.M501609200. Epub 2005 Aug 8.
Bone sialoprotein (BSP), a major protein in the extracellular matrix of bone, is expressed almost exclusively by bone cells and by cancer cells that have a propensity to metastasize to bone. Previous studies have shown that v-src stimulates basal transcription of bsp in osteosarcoma (ROS 17/2.8) cells by targeting the inverted CCAAT element (ICE) in the proximal promoter. To identify possible downstream effectors of Src we studied the effects of the proto-oncogene c-jun, which functions downstream of Src, on basal transcription of bsp using transient transfection assays. Increased expression of endogenous c-Jun induced by the tumor promoter 12-O-tetradecanoyl-phorbol 13-acetate and ectopic expression of c-Jun increased basal transcription of chimeric reporter constructs encompassing the proximal promoter by 1.5-3-fold in ROS 17/2.8 osteosarcoma cells, with more modest effects in a normal bone cell line, RBMC-D8. The effects of c-Jun were abrogated by mutations in the ICE box and by co-expression of dominant negative nuclear factor Y, subunit A (NF-YA). The increase in bsp transcription did not require phosphorylation of c-Jun and was not altered by trichostatin treatment or by ectopic expression of p300/CREB-binding protein (CBP) or mutated forms lacking histone acetyltransferase (HAT) activity. Similarly, ectopic expression of p300/CBP-associated factor (P/CAF), which transduces p300/CBP effects, or of HAT-defective P/CAF did not influence the c-jun effects. Surprisingly, E1A, which competes with P/CAF binding to p300/CBP, also stimulated BSP transcription through NF-Y independently of c-jun, p300/CBP, and P/CAF. Collectively, these studies show that c-Jun and E1A regulate basal transcription of bsp in osteosarcoma cells by recruiting the NF-Y transcriptional complex to the ICE box in a mechanism that is independent of p300/CBP and P/CAF HAT activities.
骨唾液酸蛋白(BSP)是骨细胞外基质中的一种主要蛋白质,几乎仅由骨细胞以及倾向于转移至骨的癌细胞表达。先前的研究表明,v-src通过靶向近端启动子中的反向CCAAT元件(ICE)来刺激骨肉瘤(ROS 17/2.8)细胞中bsp的基础转录。为了鉴定Src可能的下游效应器,我们使用瞬时转染实验研究了原癌基因c-jun(其在Src下游发挥作用)对bsp基础转录的影响。由肿瘤启动子12-O-十四烷酰佛波醇-13-乙酸酯诱导的内源性c-Jun表达增加以及c-Jun的异位表达,使包含近端启动子的嵌合报告基因构建体在ROS 17/2.8骨肉瘤细胞中的基础转录增加了1.5至3倍,在正常骨细胞系RBMC-D8中的影响则较小。ICE框中的突变以及共表达显性负性核因子Y亚基A(NF-YA)可消除c-Jun的作用。bsp转录的增加不需要c-Jun的磷酸化,并且不受曲古抑菌素处理或p300/CREB结合蛋白(CBP)的异位表达或缺乏组蛋白乙酰转移酶(HAT)活性的突变形式的影响。同样,转导p300/CBP效应的p300/CBP相关因子(P/CAF)的异位表达或HAT缺陷型P/CAF也不影响c-jun的作用。令人惊讶的是,与P/CAF竞争与p300/CBP结合的E1A,也通过NF-Y独立于c-jun、p300/CBP和P/CAF刺激BSP转录。总体而言,这些研究表明,c-Jun和E1A通过将NF-Y转录复合物募集到ICE框,以一种独立于p300/CBP和P/CAF HAT活性的机制来调节骨肉瘤细胞中bsp的基础转录。